In the last week, the Biotech industry is flat overall, with Nirman Agri Genetics standing out by going down 5.9%. As for the the longer term, the industry is up 11% over the past 12 months. As for the next few years, earnings are expected to grow by 20% per annum.
Has the Indian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 29 May 2025 | ₹455.5b | ₹163.8b | ₹10.6b | 55.7x | 43x | 2.8x |
Sat, 26 Apr 2025 | ₹428.5b | ₹158.8b | ₹8.5b | 53.1x | 50.2x | 2.7x |
Mon, 24 Mar 2025 | ₹457.2b | ₹158.9b | ₹8.4b | 51.2x | 54.7x | 2.9x |
Wed, 19 Feb 2025 | ₹444.2b | ₹158.9b | ₹8.4b | 50.3x | 53.2x | 2.8x |
Fri, 17 Jan 2025 | ₹523.0b | ₹159.6b | ₹14.5b | 58.4x | 36x | 3.3x |
Sun, 15 Dec 2024 | ₹480.3b | ₹159.6b | ₹14.5b | 39.3x | 33x | 3x |
Tue, 12 Nov 2024 | ₹470.3b | ₹159.0b | ₹14.3b | 39.7x | 32.8x | 3x |
Thu, 10 Oct 2024 | ₹462.8b | ₹157.7b | ₹15.7b | 31.2x | 29.4x | 2.9x |
Sat, 07 Sep 2024 | ₹492.3b | ₹157.7b | ₹15.7b | 34.5x | 31.3x | 3.1x |
Mon, 05 Aug 2024 | ₹469.4b | ₹157.3b | ₹10.4b | 41.7x | 45.3x | 3x |
Wed, 03 Jul 2024 | ₹462.7b | ₹157.4b | ₹10.4b | 44x | 44.7x | 2.9x |
Fri, 31 May 2024 | ₹401.4b | ₹157.3b | ₹10.3b | 44.8x | 39x | 2.6x |
Sun, 28 Apr 2024 | ₹396.7b | ₹155.4b | ₹12.0b | 37.5x | 33x | 2.6x |
Tue, 26 Mar 2024 | ₹328.2b | ₹155.4b | ₹12.0b | 33.1x | 27.3x | 2.1x |
Thu, 22 Feb 2024 | ₹357.5b | ₹155.4b | ₹12.0b | 42.3x | 29.7x | 2.3x |
Sat, 20 Jan 2024 | ₹361.8b | ₹145.0b | ₹5.3b | 58.7x | 68.8x | 2.5x |
Mon, 18 Dec 2023 | ₹331.2b | ₹145.0b | ₹5.3b | 54.4x | 63x | 2.3x |
Wed, 15 Nov 2023 | ₹301.7b | ₹145.0b | ₹5.2b | 53.2x | 57.6x | 2.1x |
Fri, 13 Oct 2023 | ₹341.8b | ₹133.8b | ₹4.8b | 32.1x | 71.4x | 2.6x |
Sun, 10 Sep 2023 | ₹347.4b | ₹133.8b | ₹4.8b | 30.2x | 72.7x | 2.6x |
Tue, 08 Aug 2023 | ₹340.8b | ₹120.4b | ₹4.5b | 42.1x | 75.4x | 2.8x |
Thu, 06 Jul 2023 | ₹335.5b | ₹120.4b | ₹4.5b | 41.5x | 74.4x | 2.8x |
Sat, 03 Jun 2023 | ₹313.3b | ₹120.8b | ₹4.5b | 40.1x | 69.9x | 2.6x |
Mon, 01 May 2023 | ₹309.0b | ₹106.7b | ₹16.2b | 29.1x | 19x | 2.9x |
Wed, 29 Mar 2023 | ₹269.9b | ₹106.6b | ₹16.4b | 23.6x | 16.5x | 2.5x |
Fri, 24 Feb 2023 | ₹293.2b | ₹106.3b | ₹16.3b | 34.5x | 18x | 2.8x |
Sun, 22 Jan 2023 | ₹326.2b | ₹99.2b | ₹18.0b | 31.1x | 18.2x | 3.3x |
Tue, 20 Dec 2022 | ₹347.6b | ₹99.2b | ₹18.0b | 33.8x | 19.4x | 3.5x |
Thu, 17 Nov 2022 | ₹373.7b | ₹100.5b | ₹17.3b | 35.1x | 21.7x | 3.7x |
Sat, 15 Oct 2022 | ₹347.7b | ₹95.5b | ₹18.1b | 29.9x | 19.2x | 3.6x |
Mon, 12 Sep 2022 | ₹398.0b | ₹95.5b | ₹18.1b | 34.1x | 22x | 4.2x |
Wed, 10 Aug 2022 | ₹415.0b | ₹95.8b | ₹18.3b | 33.8x | 22.7x | 4.3x |
Fri, 08 Jul 2022 | ₹420.6b | ₹92.1b | ₹17.7b | 31.3x | 23.8x | 4.6x |
Sun, 05 Jun 2022 | ₹420.9b | ₹92.0b | ₹17.5b | 31.7x | 24x | 4.6x |
24x
How does Indian Biotech compare with similar industries?
IN Market | 1.19% | |
Healthcare | 1.20% | |
Biotech | 0.84% | |
Biotech | 0.84% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
PANACEABIO Panacea Biotec | ₹545.10 | 7.4% +₹2.3b | 304.8% | PS5.9x | |
524669 Hester Biosciences | ₹1.82k | 3.5% +₹524.9m | 1.5% | PE56.4x | |
524663 Bharat Immunologicals & Biologicals | ₹26.61 | 3.7% +₹41.0m | -10.1% | n/a | |
532039 Zenotech Laboratories | ₹63.82 | 0.8% +₹29.9m | 4.1% | PE69.4x | |
532041 Hindustan Bio Sciences | ₹9.83 | 16.5% +₹14.2m | 18.6% | PE290.4x |